PRVA vs. HIMS, GH, RDNT, OPCH, SHC, BTSG, WGS, CON, SGRY, and HTFL
Should you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include Hims & Hers Health (HIMS), Guardant Health (GH), RadNet (RDNT), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), and Heartflow (HTFL). These companies are all part of the "healthcare" industry.
Privia Health Group vs. Its Competitors
Privia Health Group (NASDAQ:PRVA) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, media sentiment and valuation.
94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 10.7% of Privia Health Group shares are owned by insiders. Comparatively, 13.7% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Hims & Hers Health has a net margin of 9.63% compared to Privia Health Group's net margin of 0.78%. Hims & Hers Health's return on equity of 26.26% beat Privia Health Group's return on equity.
Privia Health Group presently has a consensus target price of $28.00, indicating a potential upside of 28.38%. Hims & Hers Health has a consensus target price of $38.92, indicating a potential downside of 11.89%. Given Privia Health Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe Privia Health Group is more favorable than Hims & Hers Health.
In the previous week, Hims & Hers Health had 43 more articles in the media than Privia Health Group. MarketBeat recorded 58 mentions for Hims & Hers Health and 15 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.37 beat Hims & Hers Health's score of 0.33 indicating that Privia Health Group is being referred to more favorably in the media.
Privia Health Group has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.08, indicating that its share price is 108% more volatile than the S&P 500.
Hims & Hers Health has lower revenue, but higher earnings than Privia Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
Summary
Hims & Hers Health beats Privia Health Group on 9 of the 17 factors compared between the two stocks.
Get Privia Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Privia Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:PRVA) was last updated on 8/28/2025 by MarketBeat.com Staff
MarketBeat All Access